Tagomics

Tagomics has developed a platform that combines "holographic" technology, including genomics (detecting gene mutations), epigenomics (studying chemical "switches" on the genome), and fragmentomics (analyzing DNA fragment patterns in the blood). By integrating these approaches and applying advanced data analysis and machine learning, the platform can help discover new cancer biomarkers and develop strategic partnerships to drive drug development and treatment options for patients.